MHRA launches new medicine alert app


The Medicines and Healthcare products Regulatory Agency (MHRA) has released a new smartphone app to increase participation of patients and clinicians in the ‘Yellow Card’ scheme, which monitors UK medicines.

As part of the Yellow Card scheme, the MHRA collates and reviews reports of suspected adverse drug reactions for licensed and unlicensed medicines and vaccines.

Currently information is related through a website, but the new app will be the first tool allowing patients, carers and healthcare professionals to report the side effects of medicines directly to the Yellow Card Scheme.

Users can choose to track specific medicines so that they receive alerts and news about them.

Mick Foy, group manager for MHRA’s Vigilance and Risk Management of medicines division said: “The contribution of patients, careers and healthcare professionals alike in reporting suspected side effects to the Yellow Card Scheme is vital. The evidence helps MHRA detect safety issues and take the necessary action to keep the public safe.

Moving Yellow Card onto a mobile app is a logical progression in this digital age, allowing us to build on the existing website to improve user engagement.

Life Sciences Minister George Freeman MP commented: “The Yellow Card Scheme has played a vital role in the safety of medicines for the last 50 years and the launch of this new mobile app brings it into the 21st century.”

The app was created in partnership with the Innovative Medicines Initiative WEB-RADR project which includes the European Commission, national regulatory authorities, businesses and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Related reading